SC
MRK icon

Stance Capital’s Merck MRK Stock Holding History

Stance Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Sell
12,319
-1,678
-12% -$194K 0.72% 36
2025
Q4 		$1.47M Sell
13,997
-2,803
-17% -$263K 0.54% 47
2025
Q3 		$1.41M Buy
16,800
+890
+6% +$73.3K 0.52% 63
2025
Q2 		$1.26M Buy
+15,910
New +$1.26M 0.47% 129
2025
Q1 		– Sell
-2,017
Closed -$201K – 185
2024
Q4 		$201K Buy
+2,017
New +$208K 0.12% 55

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stance Capital's MRK Position: Q1 2026 in Review

Stance Capital reduced its Merck (MRK) stake by 12% in Q1 2026, selling an estimated $194K and leaving 12,319 shares worth $1.48M. The position accounts for 0.72% of the portfolio, ranked #36.

Stance Capital first reported a position in MRK in Q4 2024 and has held it in 5 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Stance Capital held 12,319 shares of Merck worth $1.48M as of Q1 2026.
  • Stance Capital sold 1,678 Merck shares in Q1 2026, an estimated $194K.
  • Merck made up 0.72% of Stance Capital's portfolio in Q1 2026, its #36 holding.
  • Stance Capital first reported a position in Merck in Q4 2024 and has held it in 5 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.